Tissue-resident memory T cells (TRMs) in mice mediate optimal protective immunity to infection and vaccination, while in humans, the existence and properties of TRMs remain unclear. Here, we use a unique human tissue resource to determine whether human tissue memory T cells constitute a distinct subset in diverse mucosal and lymphoid tissues. We identify a core transcriptional profile within the CD69 subset of memory CD4 and CD8 T cells in lung and spleen that is distinct from that of CD69 TEM cells in tissues and circulation and defines human TRMs based on homology to the transcriptional profile of mouse CD8 TRMs. Human TRMs in diverse sites exhibit increased expression of adhesion and inhibitory molecules, produce both pro-inflammatory and regulatory cytokines, and have reduced turnover compared with circulating TEM, suggesting unique adaptations for in situ immunity. Together, our results provide a unifying signature for human TRM and a blueprint for designing tissue-targeted immunotherapies.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5646692 | PMC |
http://dx.doi.org/10.1016/j.celrep.2017.08.078 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!